Stents Set Up For A Comeback (ABT, BSX, MDT, JNJ, SRDX, ANPI)
Abbott Laboratories (NYSE: ABT) announced after the close today, in a decision we have been waiting on for what feels like forever, that the FDA has approved for the company to begin marketing its...
View ArticleSurModics: Investors Looking Under The Hood (SRDX, MRK, JNJ)
SurModics Inc. (NASDAQ: SRDX) is seeing a sharp drop after recent news. Its partner Merck & Co. (NYSE: MRK) is still under an agreement with the SurModics in Phase IIb I-vation trials, but Merck...
View ArticleDrug Eluting Stents Vs. Bare Metals Stents Win Again
A new study funded by the Massachusetts Department of Public Health is showing further evidence to support the use of drug eluting stents over bare metal stents in heart attack patients. This study...
View Article
More Pages to Explore .....